Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus
Gregor Ebert, Simon Preston, Cody Allison, James Cooney, Jesse G Toe, Michael D Stutz, Samar Ojaimi, Hamish W Scott, Nikola Baschuk, Ueli Nachbur, Joseph Torresi, Ruth Chin, Danielle Colledge, Xin Lie, Nadia Warner, Peter Revill, Scott Bowden, John Silke, C Glenn Begley, Marc Pellegrini
Proceedings of the National Academy of Sciences | NATL ACAD SCIENCES | Published : 2015
Awarded by National Health and Medical Research Council Australia Career Development Award
We thank Stephen Condon and Stephen Locarnini for discussions. Pei-Jer Chen and Ding-Shinn Chen constructed the hepatitis B virus infection vector for hydrodynamic injection. David Vaux generated the cellular inhibitor of apoptosis protein 1<SUP>loxP/loxP</SUP> (cIAP1<SUP>loxP/loxP</SUP>) and cIAP2<SUP>FRT/lFRT</SUP> mice. Paul Hertzog provided reagents, and Lynne Waddington assisted with EM. Linda Earnest-Silveira provided laboratory support. The following mouse strain was obtained through National Institute of Allergy and Infectious Diseases Exchange Program 04215 C57BL/6-H-2Kb-H-2Db. This work was supported by Australian Research Council Future Fellowship Award (to U.N.) and Grant FT1301000166; National Health and Medical Research Council Australia Career Development Award 637350 and Grants 541901 (to J.S.), 541902 (to J.S.), 1006592 (to M.P.), 1045549 (to M.P.), and 1065626 (to M.P.); the Victorian State Government Operational Infrastructure Support; and the Independent Research Institutes Infrastructure Support Scheme of the Australian Government National Health and Medical Research Council.